Forschungsgruppe Morrison

Publikationen

2018

  • Inflammaging impairs peripheral nerve maintenance and regeneration.
    Büttner R, Schulz A, Reuter M, Akula AK, Mindos T, Carlstedt A, Riecken LB, Baader SL, Bauer R, Morrison H
    Aging Cell 2018 (epub ahead of print)
  • Sequential use of milk and bovine serum albumin for streptavidin-probed western blot.
    Cui Y, Ma L
    Biotechniques 2018, 65(3), 125-6
  • Construction of cloning-friendly mini-genes for mammalian expression of full-length human NF1 isoforms.
    Cui Y, Morrison H
    Hum Mutat 2018 (epub ahead of print)
  • 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
    Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, Martin S, Morrison H, Pasmant E, Ratner N, Schorry E, Ullrich NJ, Viskochil D, Weiss B, Widemann BC, Zhu Y, Bakker A, Serra E
    Am J Med Genet A 2018, 176(5), 1258-69
  • Sepsis-associated encephalopathy.
    Helbing DL, Böhm L, Witte OW
    CMAJ 2018, 190(36), E1083
  • Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
    Li J, Song P, Jiang T, Dai D, Wang H, Sun J, Zhu L, Xu W, Feng L, Shin VY, Morrison H, Wang X, Jin H
    Mol Ther 2018, 26(7), 1828-39
  • Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells.
    Rauch A, Carlstedt A, Emmerich C, Mustafa AHM, Göder A, Knauer SK, Linnebacher M, Heinzel T, Krämer OH
    Oncotarget 2018, 9(45), 27835-50
  • Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities.
    Schulz A, Grafe P, Hagel C, Bäumer P, Morrison H, Mautner VF, Farschtschi S
    Exp Neurol 2018, 299(Pt B), 334-44
  • Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
    Synodos for NF2 Consortium, Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN
    PLoS One 2018, 13(6), e0197350
  • Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
    Toledo* A, Grieger* E, Karram K, Morrison H, Baader SL
    PLoS One 2018, 13(5), e0196726 * equal contribution